DEC 21, 2017 06:11 AM PST

Monocyte Diversity Vital for Personalized Cancer Immunotherapy

WRITTEN BY: Kara Marker

Plucking monocytes out of the human bloodstream is one approach to creating personalized cancer treatments, but this immunotherapy approach hasn’t been as successful as scientists hoped it would be. After learning more about monocytes in a new study from the University of Bonn, scientists and their collaborators learn that these cells are much more diverse than they realized.

Dendritic cells in the corneal epithelium. Credit: Wikimedia user Zhiguo.he

Monocytes are circulating white blood cells of the immune system that are made in the bone marrow before they enter the bloodstream and eventually differentiate into the so-called antigen-presenting cells of the immune system: macrophages, phagocytic immune cells, or dendritic cells.

In the past, scientists have extracted monocytes from the blood of cancer patients to use for immunotherapy, creating monocyte-derived dendritic cells (moDCs) to activate the immune system against tumor cells. However, this therapy approach is rarely effective - why? Can it be made more effective?

The new study, published in the journal Immunity, helped scientists realize that moDCs are not identical descendents of dendritic cells; instead, they are actually quite diverse. To analyze moDCs in their new study, scientists isolated monocytes from human blood samples and transformed the cells into different types of antigen-presenting cells.

"Using state-of-the-art computer-assisted models, we were able to show that moDCs differ from dendritic cells and present a mixture of cells with very diverse properties and functions,” explained lead author Jil Sander.

The variety of moDCs likely explains why cancer immunotherapy based on these cells works in so few patients. However, researchers believe that the moDCs could be altered to fit individual cases of cancer, enhancing the immunotherapy’s success rate.

"MoDCs have an extraordinarily large plasticity, enabling them to tailor their response to pathogens, tumors or endogenous danger signals,” explained second lead author Dr. Susanne V. Schmidt. “This ability is fine-tuned by specific gene regulation.”

Sources: PubMed Health, University of Bonn

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 04, 2018
Immunology
AUG 04, 2018
Infant's Innate Immune Response
An infant's innate immune response develops from fetus to birth, but it may not be as "immature" as previously thought....
AUG 17, 2018
Health & Medicine
AUG 17, 2018
Is Influenza Different in Obese Patients?
There are many health risks for obese patients. Cardiovascular disease, diabetes and even some forms of cancer. The immune system can be disrupted when a p...
AUG 29, 2018
Immunology
AUG 29, 2018
Immune System Prioritizes Response when Faced with Multiple Threats
The Innate Immune response prioritizes lung infection and cell repair over other threats in both infants and adults....
OCT 09, 2018
Immunology
OCT 09, 2018
Complement Function Expands
Additional roles to complement protein C3 have been described in work performed by a team of researchers at the Lund University in Sweden...
OCT 22, 2018
Immunology
OCT 22, 2018
Barcoding for Cancer Immunity Genes
Scientists develop a novel technology that allows for protein barcoding to reveal gene function...
NOV 19, 2018
Cell & Molecular Biology
NOV 19, 2018
How Mitochondria can Help the Cell Fight Pathogens
Some pathogens can get around out bodies' natural defense mechanisms. So our body developed a Plan B....
Loading Comments...